Research Use Only  •  Third-Party Tested  •  COA Documentation

Revive Advanced Copper Peptide Gel

Advanced Topical Peptide Gel

Revive Advanced Copper Peptide Gel

GHK-Cu Copper Tripeptide-1 and Organic Boswellia Serrata Extract in GW Bio Health's proprietary R3a™ hydrogel delivery platform — supplied for peptide, hydration and renewal research only.

$50.00

In Stock

1

For Research Use Only — Not For Human Or Veterinary Use

GHK-Cu Copper Peptide

Advanced copper tripeptide research compound.

Organic Boswellia

Boswellia Serrata extract incorporated into the R3a™ delivery matrix.

R3a™ Technology

Proprietary nano-delivery platform engineered around ~32 nm carrier architecture.

Hydrogel Matrix

Designed to transition from fluid to gel as temperature increases.

Dual-Phase Platform

Combines aqueous and colloidal delivery environments in one formulation.

Made in USA

According to the manufacturer's product specifications.

Powered by GW Bio Health Technology

R3a™ Hydrogel Topical Delivery Platform

Authorized Elev8 Health Distributor & Partner

Third-Party Tested

COA Documentation

Research-Grade

Batch Traceability

Elev8 REVIVE is a premium topical research formulation combining GHK-Cu Copper Tripeptide-1 with Organic Boswellia Serrata Extract in GW Bio Health's proprietary R3a™ delivery platform.

Rather than relying on a traditional bulk-oil emulsion, the platform is engineered around molecular dispersion and small carrier structures — a dual-phase system pairing an aqueous copper-peptide phase with molecularly delivered boswellic acids.

The lightweight hydrogel is designed to transition from a fluid consistency into a semi-solid hydrogel above approximately 32°C, a formulation property intended to hold the matrix and its incorporated actives together under defined research conditions.

Technology descriptions are based on technical information supplied by GW Bio Health and describe the engineering rationale of the platform. They should not be interpreted as guaranteed outcomes. This formulation is supplied for laboratory research use only and is not intended for human or veterinary use.

REVIVE Advanced Copper Peptide Gel is a topical-format research formulation built around GHK-Cu Copper Tripeptide-1 and Organic Boswellia Serrata Extract, combining peptide science with GW Bio Health's proprietary R3a™ delivery platform. The formulation uses a dual-phase approach: lipophilic boswellic acids are incorporated into the R3a colloidal matrix, while GHK-Cu is carried within the aqueous phase. The lightweight formulation is engineered to undergo a temperature-dependent transition into a hydrogel above approximately 32°C, providing a stable matrix for investigating peptide delivery, molecular hydration and renewal-related research models. Technology descriptions are based on technical information supplied by GW Bio Health and should not be interpreted as guaranteed outcomes. For Research Use Only. Not intended for human or veterinary use.

Key Research Compounds

Peptide Science Meets Botanical Actives

Two specifically identified actives, delivered through two complementary environments in a single lightweight hydrogel.

01

Copper Tripeptide-1

GHK-Cu

GHK-Cu is the primary peptide active in REVIVE. The GW Bio Health formulation describes the copper peptide as being carried in the aqueous phase alongside the R3a colloidal delivery system.

Together they create a dual-component formulation used in renewal- and matrix-related research models.

02

Botanical Active

Organic Boswellia Serrata Extract

Boswellia provides naturally occurring boswellic acids. The R3a platform is designed to carry these lipophilic compounds in an approximately 32 nm bonded colloid.

This allows the botanical active to be incorporated into the same delivery matrix as the peptide.

GW Bio Health Technology

R3a™ Nano-Delivery Technology

Two Delivery Environments. One Matrix.

The GW Bio Health system is designed to create molecular dispersion and small carrier structures rather than relying on a traditional bulk-oil emulsion, with an engineered carrier size of roughly 32 nm.

Colloidal Phase

Boswellic Acids

Lipophilic boswellic acids are incorporated into the R3a bonded colloid — an approximately 32 nm carrier architecture.

Aqueous Phase

GHK-Cu

The copper peptide is carried in the aqueous phase alongside the colloidal system, keeping both actives within the same hydrogel matrix.

Fluid at Ambient Temp~32–37°CHydrogel

The formulation is described as fluid at ambient temperature, transitioning into a hydrogel across an approximately 32–37°C range — a matrix engineered to retain incorporated compounds and release them gradually under controlled conditions.

Hyper-Hydration™ Matrix

Designed in Five Stages

GW Bio Health describes its topical technology as a Hyper-Hydration™ system. According to the developer, the delivery matrix is designed to:

  1. 1

    Disperse compatible actives at the molecular level.

  2. 2

    Maintain colloidal stability across the carrier phase.

  3. 3

    Transition into a semi-solid hydrogel at approximately 32–37°C.

  4. 4

    Interact with glycosaminoglycan and hyaluronic-acid-containing research substrates.

  5. 5

    Bind water within the matrix.

These stages describe the developer's platform design under controlled laboratory conditions. They have not been demonstrated specifically for GHK-Cu in the finished REVIVE formulation, and are not claims of performance in any living subject.

Research Focus

Areas of Formulation Research

The source formulation is associated with several areas of published delivery-system research. Elev8 presents these strictly as research areas — never as expected or guaranteed outcomes.

Molecular hydration

Peptide-mediated renewal models

Elasticity and firmness models

Matrix texture characterization

Moisture retention

Hydrogel-based delivery science

Human research is presented for scientific and educational context only. Elev8 Health does not recommend that its products be used for anything other than laboratory research purposes, and does not recommend human or veterinary use of any kind.

Our Technology Partner

GW Bio Health

R3a™ · Hyper-Hydration™

GW Bio Health is the developer of the R3a™ delivery platform and Hyper-Hydration™ topical matrix technology behind REVIVE Advanced Copper Peptide Gel.

Elev8 Health participates as an approved distributor and partner for this technology, bringing the formulation to the Elev8 platform through our branded research catalog.

Technology and intellectual-property rights remain with their respective owners.

Frequently Asked

REVIVE, Explained

R3a™, Hyper-Hydration™, and related technology names are associated with GW Bio Health and their respective intellectual-property owners. Elev8 Health is an authorized distribution and brand partner for this technology. This product is intended solely for laboratory and research purposes. It is not intended to diagnose, treat, cure, or prevent any disease and is not intended for human consumption or therapeutic use. Information provided is for educational and research purposes only.

For Research Use Only — Not For Human Or Veterinary Use

$50.00

Elev8 Health — Research Compounds Division

Research Compounds Division

Science. Research. Elevated.

A research compounds division built around documented quality and multiple research delivery platforms.

Elev8 Health LLC — a limited liability company formed in Wisconsin, operating as a legal reseller of independently manufactured research materials, with a national sales team and a major hub in South Louisiana.

Shop

Research

Company

Elev8 research products are offered strictly for laboratory, analytical, educational and scientific research purposes unless expressly identified otherwise. They are not intended for human consumption, veterinary use, food use, self-administration, diagnosis, treatment, prevention, mitigation or therapeutic application.

Elev8 Health LLC is a limited liability company formed and registered in the State of Wisconsin. Elev8 Health is a reseller and distributor of research materials — not a chemical manufacturer. Elev8 Health does not manufacture, synthesize, compound or chemically alter any product it offers, and is not a compounding pharmacy or compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility under Section 503B.

Elev8 Health collects payment for research materials it has purchased from its suppliers and resells in its own name, and also collects payment as an authorized agent on behalf of Great Works LLC for products supplied by that entity. Amounts collected on behalf of Great Works LLC are remitted to Great Works LLC. The entity responsible for supplying a given product is identified on request.

For Research Use Only  •  Not For Human Or Veterinary Use

© 2026 Elev8 Health LLC — Research Compounds Division. All rights reserved.

Admin Login